The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Dechert LLP

1095 AVENUE OF THE AMERICAS, NEW YORK, NY 10036-6797, USA
Tel:
Work +1 212 698 3500
Fax:
Fax +1 212 698 3599
Email:
Web:
www.dechert.com

David S Rosenthal

Tel:
Work +1 212 698 3616
Email:
Dechert LLP

Work Department

Corporate

Career

David S. Rosenthal, co-chair of Dechert’s Global Corporate Finance and Capital Markets practice, represents publicly and privately held corporations, investment banks, and venture capital firms focused on the life sciences and medical device, technology, media, and other growth sectors. He represents clients in corporate finance transactions, mergers and acquisitions, joint ventures, licensings and strategic alliances.

Education

Wesleyan University, B.A., 1978, cum laude; Boston University School of Law, J.D., 1981, cum laude


United States: Finance

Capital markets: debt offerings

Within: Capital markets: debt offerings

Dechert LLP has an active debt practice, which stands out for its niche expertise in life sciences and permanent capital vehicles, especially business development companies. In a recent example of its work in this area, Philadelphia-based partners Kenneth Young and Gregory Schernecke advised business development company Corporate Capital Trust on a private offering of $140m of senior notes. Boston-based corporate finance specialist Thomas Friedmann co-chairs the capital markets group and assisted Eagle Point Credit Company with several recent deals, including handling its $31.6m public notes offering. David Rosenthal co-chairs the department from New York.

[back to top]

Capital markets: equity offerings

Within: Capital markets: equity offerings

At Dechert LLP, Boston-based group co-head Thomas Friedmann is well known for his specialist skill set in acting for business development companies. In a recent example, Friedmann advised Eagle Point Credit on its $30.3m public offering. The firm is also active on behalf of underwriters, with Philadelphia-based partners James Lebovitz and Gregory Schernecke advising the underwriters on Amicus Therapeutics’ $258.8m public offering. David Rosenthal co-leads the practice from New York and with Schernecke acted for the joint book-running managers on Inovio Pharmaceuticals’ $75m public offering. Other key clients include Franklin Square Capital Partners, Golub Capital and Stifel Nicolaus.

[back to top]

Capital markets: global offerings

Within: Capital markets: global offerings

Dechert LLP’s strong focus on life sciences and permanent capital vehicles ensures a steady stream of work for clients in those areas. Among its work for the latter, Philadelphia-based partners Kenneth Young and Gregory Schernecke assisted business development company Corporate Capital Trust with its $140m private notes offering. Elsewhere, New York’s David Rosenthal, acting with the Paris office, advised the joint lead managers and book-runners on Biom’Up’s €38.1m IPO in Paris.

[back to top]

Capital markets: high-yield debt offerings

Within: Capital markets: high-yield debt offerings

Dechert LLP houses a robust issuer-side practice, which has specialist expertise in advising life sciences companies and permanent capital vehicles. Boston-based Thomas Friedmann co-heads the department and led advice to Eagle Point Credit Company on several deals over the past year, including on its $31.6m notes offering. Stephen Leitzell - who is a key name in Philadelphia - advised B&G Foods on a $500m notes offering. New York’s David Rosenthal co-chairs a team that also includes James Lebovitz and newly made-up partner Gregory Schernecke - both of whom operate from Philadelphia.

[back to top]

United States: Industry focus

Healthcare: life sciences

Within: Healthcare: life sciences

At Dechert LLP, the group is known for its expertise in patent litigation, as well as regulatory and transactional matters. In Philadelphia, George Gordon, who specializes in antitrust matters, has been defending Lannett Company against price-fixing claims, while Martin Black successfully represented Svenska Cellulosa (SCA) in a patent infringement dispute regarding the client’s hygiene product. Boston-based practice co-chair Andrea Reid assisted Nimbus Therapeutics with the development and implementation of a patent portfolio strategy regarding a program for patients with autoimmune disorders. The group is also led by New York-based David Rosenthal and also includes David Schulman in Washington DC.

[back to top]


Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • THE VAT E-COMMERCE PACKAGE

    A. INTRODUCTION   The VAT E-commerce Package adopted by the Council on the 5th of December 2017 includes several changes that will be gradually implemented, some changes will be effective as from the 1st of January 2019 and the rest as from the 1st of January 2021.
  • Doing business in Ukraine: turning point for the currency control in Ukraine

    One of the most hotly discussed topics in 2019 is currency control liberalization in Ukraine.The currency control liberalization was one of Ukraine’s priorities under the EU-Ukraine Association Agreement. At the beginning of 2019 the National Bank of Ukraine (hereinafter the “NBU”) approved and promulgated all long-awaited regulations, serving as the basis for a new liberal system of foreign currency control. The new currency control system will be launched on 7 February 2019, the same day as the Law of Ukraine  On Currency and Exchange Transactions  becomes applicable. The changes are aimed at deregulation, facilitating cross-border transactions with foreign currency and expanding the list of available foreign currency transactions.
  • New Long Term Residency Visas

    After much media coverage, Cabinet Decision 56 of 2018 (the Decision ) has been gazetted which introduces new long term residency visas to, amongst others, four categories of persons in the UAE. 
  • Significant Changes to Civil Procedure Code

    Significant changes to Federal Law No 11 of 1992 (the Civil Procedure Code ) will soon be coming into effect. These changes are introduced through regulations (the Regulations ) issued under the Civil Procedure Code and will come into effect on 16 February 2019.
  • Merger Clearance Matters

    The United Arab Emirates (the UAE ) promulgated legislation to specifically address the regulation of competition (being Federal Law 4 of 2012, or the Competition Law ) several years ago but until recently, it has been the case that the requisite implementing regulations and processes were not in place. This is no longer the case. Not only have the much anticipated implementing regulations been issued, the UAE Ministry of Economy (the Ministry ) (being the regulator in charge of administering the UAE competition regime) has now formed the required committee and issued the anticipated guidance and forms to allow concerned parties to make merger clearance submissions to the Ministry where required to do so pursuant to the Competition Law. 
  • Korean TR, Finally and Officially Coming Soon

    Korean TR, Finally and Officially Coming Soon
  • Key Changes to Korean Labor Standards Act in 2019

    Key Changes to Korean Labor Standards Act in 2019
  • fwp helps find a new mega arena location

    fwp helps find a new mega arena location
  • Direction of Financial Regulatory Environment of Korea in 2019: Legislation Supporting Financial Inn

    Direction of Financial Regulatory Environment of Korea in 2019: Legislation Supporting Financial Innovation and Reform of Supervisory System
  • WORLD SHIPPING LAW FORUM, ATHENS JANUARY 2019

    Stelios Americanos & Co LLC, participated in WORLD SHIPPING LAW FORUM in Athens that has taken place on the 25th January 2019. The conference took place at N.J.V. Athens Plaza.